Product Information

FOSFOMYCIN 3 GM SACHET is a generic product labeled by Xiromed LLC, priced at $25.4734 per EA under NDC 70700026899. Its NADAC has been published 196 times since Feb 22, 2023.

FDA first approved this application on Oct 6, 2020. Its Orange Book therapeutic-equivalence code is AA.

FOSFOMYCIN 3 GM SACHET

Granules for Oral Solution
$25.4734per EA

Strength

3 g/1

Manufacturer

Xiromed LLC

NDC

70700026899

Classification

Generic

Dosage Form

POWDER

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FOSFOMYCIN TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA212548

FDA Approved

10/6/2020

TE Code

AA

On Market Since

10/6/2020

Price Statistics

The NADAC for FOSFOMYCIN 3 GM SACHET has been published 196 times since Feb 22, 2023, and over the history we have for it it has declined 54.4%. The table below summarizes its recorded NADAC range and movement.

Current price$25.4734 per EA
All-time high$57.1818 (Jun 14, 2023)
All-time low$25.4734 (Nov 18, 2026)
52-week high$36.8749
52-week low$25.4734
Median price$41.0937
Average price$41.1690
Largest weekly change-35.0% (Apr 17, 2024)
Weeks tracked196
Tracking sinceFeb 22, 2023

Price History

1W

-3.4%

1M

-2.8%

3M

-4.8%

6M

-19.5%

1Y

-24.8%

3Y

-42.2%

5Y

N/A

All

-54.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FOSFOMYCIN 3 GM SACHET?

The current National Average Drug Acquisition Cost (NADAC) for FOSFOMYCIN 3 GM SACHET, manufactured by Xiromed LLC, is $25.4734 per EA (NDC 70700026899), effective Nov 18, 2026.

How has the price of FOSFOMYCIN 3 GM SACHET changed over time?

Over the history we have for it, the NADAC for FOSFOMYCIN 3 GM SACHET has declined 54.4%. It has been tracked across 196 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for FOSFOMYCIN 3 GM SACHET?

Since Feb 22, 2023, the NADAC for FOSFOMYCIN 3 GM SACHET has ranged from a low of $25.4734 (Nov 18, 2026) to a high of $57.1818 (Jun 14, 2023), with a median of $41.0937 per EA.

Are there cheaper alternatives to FOSFOMYCIN 3 GM SACHET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FOSFOMYCIN 3 GM SACHET in a comparable dosage form, but none are currently priced below it.

Who manufactures FOSFOMYCIN 3 GM SACHET?

FOSFOMYCIN 3 GM SACHET (NDC 70700026899) is labeled by Xiromed LLC, and CMS classifies it as a generic product.